FDA Investigator Gloria E Parra

Gloria E Parra has inspections in 3 countries as of 07 Sep 2023. Gloria E Parra has collaborated with a combinined 1379 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

07 Sep 2023

Investigator Role:

FDA Investigator

Redica ID:

100001973

Country:

United States of America, United Kingdom of Great Britain and Northern Ireland, Switzerland

Co-Investigator(s):

Alia Legaux, Amy W Yan Mai, Anita Narula, PhD, Ariel Cruz Figueroa, Arsen Karapetyan, Barbara M Frazier, Burnell M Henry, Chikako Torigoe, PhD, Christian D Lynch (CDL), Donald J Ullstrom, Dr. Gang Wang, PhD, Edwin Melendez, Esteban Beltran, Evelyn Taha, Gary T Greco, Gene D Arcy, George Pyramides, Gloria Parra, Hasan A Irier, PhD, Haydee B Romero, Irina Gaberman, Jacqueline Mdiaz Albertini, Jagdish R Amin, James A Liubicich, James L Dunnie, Jr, Jason K Morgan, Jessica M Monteiro, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Junho Pak, Larry K Austin, Laura M Howard, Laura Schankweiler, Leena Thomas, Li Hongpaul Yeh, PhD, Lisa Mathew, LTJG Matthew R Palo, Matthew A Spataro, Melissa D Ray, Mercy O Quagraine, Michael A Charles, Michael Dominick, Michael E Maselli, Michael R Dominick, Michael R Goga, Michelle Y Clark Stuart, Mohammad Heidaran, PhD, Mohsen Rajabi Abhari, FDA, Mra Mcculloughj, Niketa Patel, Parul M Patel, Patricia Fhughes Troost, Patrick L Wisor, Peter Abel, Prabhu P Raju, Rebecca E Dombrowski, Reyes Candau Chacon, PhD, Samina S Khan, Sandra D Thompson, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Steven M Weinman, Thomas J Arista, Thomas W Nojek, Thuy T Nguyen, LCDR, Tina M Pawlowski, Torrance J Slayton, Uduak M Inokon, Valerie Grecek Trinh, Valerie J Grecek Trinh, Wayne E Seifert, Xianghong Jing (Emily), PhD, Yumi J Hiramine

Gloria E Parra's Documents

Publish Date	Document Type	Title
November, 2003	FDA 483	Norton Healthcare Limited - Form 483, 2003-11-04
September, 2002	EIR	Pfizer, Inc. - EIR, 2002-09-27
May, 2001	FDA 483	New York Blood Center, Inc. - Form 483, 2001-05-21
May, 2001	FDA 483 Response	New York Blood Center, Inc. - Form 483R, 2001-08-15
November, 2002	FDA 483	Senn Chemicals AG - Form 483, 2002-11-21
November, 2002	FDA 483 Response	Senn Chemicals AG - Form 483R, 2002-12-20
May, 2001	EIR	New York Blood Center, Inc. - EIR, 2001-05-21
November, 2002	EIR	Senn Chemicals AG - EIR, 2002-11-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more